Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Patients with EMD undergoing FDG PET/CT for metabolic response assessment may get better prognostic discrimination with total lesion glycolysis vs. Deauville Scores; multivariable analysis finds TLG independently prognostic.”
Title: Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis
Authors: Saurabh Zanwar, Gokce Belge Bilgin, Stephen M. Broski, Matthew Thorpe, Cem Bilgin, Wilson Gonsalves, Prashant Kapoor, Taxiarchis Kourelis, Suzanne Hayman, Nadine Abdallah, Moritz Binder, Joselle Cook, Angela Dispenzieri, David Dingli, Morie A. Gertz, Nelson Leung, Yi Lin, Eli Muchtar, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar
You can read the Full Article in Leukemia.
You can find more posts featuring Robert Orlowski on OncoDaily.